1. Home
  2. ARBB vs IMNN Comparison

ARBB vs IMNN Comparison

Compare ARBB & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

HOLD

Current Price

$5.51

Market Cap

10.5M

Sector

Technology

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$3.11

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBB
IMNN
Founded
1997
1982
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
12.5M
IPO Year
2023
1985

Fundamental Metrics

Financial Performance
Metric
ARBB
IMNN
Price
$5.51
$3.11
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$20.00
$182.61
AVG Volume (30 Days)
26.2K
41.6K
Earning Date
11-03-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,842,655.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$24.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
239.12
N/A
52 Week Low
$3.92
$2.99
52 Week High
$18.60
$41.22

Technical Indicators

Market Signals
Indicator
ARBB
IMNN
Relative Strength Index (RSI) 40.85 32.98
Support Level $5.72 $3.28
Resistance Level $7.34 $3.89
Average True Range (ATR) 0.40 0.20
MACD -0.06 -0.04
Stochastic Oscillator 2.86 2.38

Price Performance

Historical Comparison
ARBB
IMNN

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: